<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04115566</url>
  </required_header>
  <id_info>
    <org_study_id>18-27002</org_study_id>
    <nct_id>NCT04115566</nct_id>
  </id_info>
  <brief_title>Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository</brief_title>
  <acronym>HS PROGRESS</acronym>
  <official_title>Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly&#xD;
      understood and understudied. As a result, little is known about disease prognosis and few&#xD;
      effective treatments exist for this condition. This prospective observational cohort study&#xD;
      aims to comprehensively characterize the clinical and biological features of HS. The results&#xD;
      of this research will provide a basis for the development of an HS clinical classification&#xD;
      system and identification of potential treatments for HS.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2020</start_date>
  <completion_date type="Anticipated">September 1, 2029</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2029</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Primary Objective</measure>
    <time_frame>2019-2029</time_frame>
    <description>The primary aim of this study is to identify clinical and biologic characteristics of hidradenitis suppurativa.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary Objective</measure>
    <time_frame>2019-2029</time_frame>
    <description>Secondary aims include correlating alterations in clinical and biological characteristics with disease status, and identifying genetic variants that predict disease progression or response to therapy.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Hidradenitis Suppurativa</condition>
  <eligibility>
    <study_pop>
      <textblock>
        HS Patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or female â‰¥ 10 years of age&#xD;
&#xD;
          2. Diagnosis of HS by a dermatologist or practitioner experienced in making a diagnosis&#xD;
             of HS&#xD;
&#xD;
          3. Written informed consent (and assent when applicable) obtained from subject or&#xD;
             subject's legal representative and ability for subject to comply with the requirements&#xD;
             of the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        1. Inability to give informed consent or unavailability of a parent/guardian who is able&#xD;
        and willing to give informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Haley B Naik, MD, MHSc, FAAD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maggie Kudlinski</last_name>
    <phone>415-502-4741</phone>
    <email>margaret.kudlinski@ucsf.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of California San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Haley B Naik, MD, MHSc, FAAD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>September 18, 2019</study_first_submitted>
  <study_first_submitted_qc>October 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 4, 2019</study_first_posted>
  <last_update_submitted>December 15, 2020</last_update_submitted>
  <last_update_submitted_qc>December 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hidradenitis Suppurativa</mesh_term>
    <mesh_term>Hidradenitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

